The African Development Bank Group ( ) has finalised a loan of up to $15 million to the Biologicals and Vaccines Institute of South Africa Ltd (Biovac) ( ...
New data supports the idea that Merck’s Ebola vaccine Ervebo, licensed to target the Zaire species of ebolaviruses, could ...
The Bundibugyo strain of the Ebola virus has been devastating the Democratic Republic of the Congo, with no vaccine currently ...
A stepwise HIV vaccine strategy has induced broadly neutralizing antibodies in primates, hinting that a truly protective HIV ...
With the COVID-19 pandemic exposing the critical need for domestic vaccine production, Korea signaled Friday that it intends ...
Ebolaviruses are among the most dangerous known human pathogens. Three ebolavirus species have repeatedly caused major ...
Vaxcyte's VAX-31 is in a Phase 3 pivotal OPUS-1 noninferiority trial and is expecting topline data in 4Q 2026. Learn more ...
Qdenga, cleared this week for ages 4 to 60, is one of only a few dengue vaccines in the world. It is to be injected in two ...
The Indian Council of Medical Research (ICMR) has licensed three indigenous biomedical technologies to leading Indian ...
Fact check - The narrative mixes a number of scientific terms related to vaccines and then draws a false conclusion.
India has approved QDENGA, its first dengue vaccine. A pulmonary specialist explains who should get vaccinated, who should ...
ICMR licensed three indigenous biomedical technologies to Emcure and Biological E, advancing an HPV precancer therapy and vaccines for typhoid, paratyphoid and Shigella toward affordable commercial ...